1 – 10 of 10
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
- Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer (
- Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials (
- Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study (
- The path to a better biomarker: application of a risk management framework for the implementation of PD‐L1 and TILs as immuno‐oncology biomarkers into breast cancer clinical trials and daily practice (
- 2019
- Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration (
- The circular RNome of primary breast cancer (
- 2018
- Abstract P2-03-01: Analytical validation of a standardized scoring protocol for Ki67 assessed on breast excision whole sections: An international multicenter collaboration (
- 2017
- Societal challenges of precision medicine : Bringing order to chaos (
- 2016
- Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration (
- 2015
- An international study to increase concordance in Ki67 scoring. (